NPI: 1942276134 · WASHINGTON, DC 20002 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/27/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/27/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,206 | $258K |
| 2019 | 15,307 | $248K |
| 2020 | 15,369 | $203K |
| 2021 | 17,628 | $200K |
| 2022 | 19,463 | $378K |
| 2023 | 7,830 | $349K |
| 2024 | 3,782 | $330K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 34,938 | 2,566 | $1.81M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,980 | 1,358 | $112K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 712 | 286 | $25K |
| J1756 | Injection, iron sucrose, 1 mg | 7,025 | 1,640 | $19K |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,467 | 1,367 | $4K |
| 83970 | 1,740 | 1,317 | $363.14 | |
| 90674 | 36 | 24 | $201.42 | |
| 82728 | 1,447 | 1,152 | $117.45 | |
| 83540 | 1,503 | 1,195 | $54.32 | |
| 83550 | 812 | 577 | $51.22 | |
| G0008 | Administration of influenza virus vaccine | 63 | 43 | $32.00 |
| 85041 | 1,374 | 1,057 | $24.60 | |
| 85048 | 1,379 | 1,061 | $20.65 | |
| 84466 | 523 | 470 | $0.00 | |
| 82108 | 15 | 15 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 4,516 | 1,788 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 55 | 38 | $0.00 |